Pluristyx
PrivateLast Round
Series A
Jul 1, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Pluristyx operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Convertible Debt round in July 2025.
Pluristyx is a biotechnology company that provides induced pluripotent stem cell (iPSC) products, contract development, and manufacturing services to accelerate the development of cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pluristyx Comparables
Compare Pluristyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellistic | 78% | |
| Ncardia | 77% | |
| bit.bio | 77% |
For institutional investors. Book with your work email.
Pluristyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2026 | ||||
| Grant | Nov 17, 2025 | ||||
| Convertible Debt | Jul 28, 2025 | ||||
| Early Funding | Dec 21, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pluristyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JDRF | Grant |
| BroadOak Capital Partners | Convertible Debt, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2026
Grew 19% QoQ, from 16 to 19 employees.
- Aug 22, 2026
Monthly visitors increased 41% MoM.
For institutional investors. Book with your work email.
Pluristyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pluristyx's valuation, stock price, and market status.
Is Pluristyx a public or private company?
Pluristyx is a private company.
What is the current stock price of Pluristyx?
Pluristyx is a private company, so its shares have no public market price. Caplight tracks Pluristyx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pluristyx worth (valuation)?
Valuation information for Pluristyx is not publicly available.
Can I buy Pluristyx stock?
Pluristyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pluristyx's last funding round?
Pluristyx's most recent funding round was Series A on July 1, 2026.
Who are the main investors in Pluristyx?
Key investors in Pluristyx include BroadOak Capital Partners.
Will Pluristyx IPO soon?
No public IPO plans have been announced for Pluristyx.
How can I track Pluristyx secondary market activity?
Caplight tracks bids, offers, and trades in Pluristyx's shares on secondary markets.